NITIN BAWA: Open Payments
NPI 1972536266 · DESTIN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 38 payments from 18 companies in 2025. Trend: 2023 $1,848 · 2024 $1,086 · 2025 $940
Food & beverage: $940
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $235 |
| Lundbeck LLC | 4 | $99 |
| MERZ NORTH AMERICA, INC. | 2 | $93 |
| IBSA Pharma Inc. | 4 | $88 |
| PFIZER INC. | 3 | $65 |
| Corium, LLC | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Corcept Therapeutics | 1 | $40 |
| Lilly USA, LLC | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $27 |
Products named: Tirosint, VYEPTI, NURTEC ODT, Azstarys, BOTOX, Korlym, REXULTI, QULIPTA.
Industry payments across FL — which companies pay providers there.
